Synergistic neutralization of human immunodeficiency virus type 1 by a chimpanzee monoclonal antibody against the V2 domain of gp120 in combination with monoclonal antibodies against the V3 loop and the CD4-binding site.
Synergistic neutralization of human immunodeficiency virus type 1 (HIV-1) was observed in studies using a chimpanzee anti-V2 monoclonal antibody (MAb), C108G, in combination with anti-V3 loop and anti-CD4 binding-site (bs) MAbs of different epitope specificities. C108G paired with either of two anti...
Gardado en:
| Publicado en: | J Virol |
|---|---|
| Principais autores: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1996
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC190381/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8676471/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.70.7.4466-4473.1996 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|